SEP 14, 2020 8:35 AM PDT

Why Defects in One Gene Can Lead to Cancer in Kids

WRITTEN BY: Carmen Leitch

While they may occur in adults, a rare, aggressive type of brain cancer called atypical teratoid rhabdoid tumors (ATRTs) tend to happen in children aged three or younger. There are some treatments for the disease, but long-term survival is poor, and there is no definitive standard for treating these patients.

Image credit: Needpix

Researchers have traced ATRT to the inactivation of a gene called SMARCB1. The gene encodes for a protein that's part of a complex that plays a role in the regulation of gene expression and certain developmental processes. Reporting in Genes & Development, a team of scientists has now outlined how the disruption in SMARCB1 disrupts neurodevelopment and encourages the growth of tumors.

"Previous research has established that, unlike some cancers, ATRT is predominantly associated with the functional loss of a single gene: SMARCB1, which leads to tumor development through changes in how genes are expressed rather than the combined effect of multiple gene mutations," explained the senior author of the study Frank Furnari, Ph.D., a professor of pathology at the University of California San Diego and Ludwig San Diego member.

"ATRT is a very deadly cancer with very few effective therapies, which are complicated by the negative effects of radiation upon the child's cognitive development. We need targeted therapeutics and to create those, we need to better understand the mechanisms driving ATRT."

In this study, the researchers assessed how depleting SMARCB1 affected human induced pluripotent stem cells. These stem cells were then programmed to become either neurons or cerebral organoids, which are simplified models of the human brain that carry several cell types.

When SMARCB1 was lost, it affected the development of neurons in a way that caused cells to resist final differentiation, and disrupted the maintenance of cellular health. These defective cells shared features with patient tumors. The researchers are hopeful that this new data will open up more effective treatment options for ATRT.

"With this new information in hand, our plan is to use our ATRT model and look for therapeutic targets that will cause these tumors to fully differentiate and therefore stop growing, which could prove to be an effective future therapy for ATRT," said the first study author Alison Parisian, a graduate student in the Funari lab.

Sources: AAAS/Eurekalert! via University of California San Diego, Genes & Development

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 18, 2020
Coronavirus
How Coronavirus Spread in the US and Europe
SEP 18, 2020
How Coronavirus Spread in the US and Europe
Researchers are beginning to examine how the world's response to the pandemic virus SARS-CoV-2 went wrong, and right ...
SEP 24, 2020
Cardiology
Analyzing Genetic Mutations in Pulmonary Arterial Hypertension
SEP 24, 2020
Analyzing Genetic Mutations in Pulmonary Arterial Hypertension
With the advancement of genomics and genome sequencing, it has become possible for researchers to study diseases down to ...
SEP 23, 2020
Microbiology
Poxvirus Made Harmless After Removing One Gene
SEP 23, 2020
Poxvirus Made Harmless After Removing One Gene
Poxviruses are deadly viruses that are known to infect both animals and humans. Cowpox and monkeypox are both known to s ...
OCT 18, 2020
Genetics & Genomics
'Silent' Mutations Might Have Given SARS-CoV-2 an Edge
OCT 18, 2020
'Silent' Mutations Might Have Given SARS-CoV-2 an Edge
The pandemic virus SARS-CoV-2 is thought to have originated in bats, like many viruses. To make the leap and infect anot ...
NOV 16, 2020
Genetics & Genomics
Hidden Genes in the SARS-CoV-2 Genome
NOV 16, 2020
Hidden Genes in the SARS-CoV-2 Genome
It's essential for organisms to use their genomes to make proteins, and the processes of transcription and translation a ...
NOV 23, 2020
Genetics & Genomics
Unusual Mutation Acts as a Kind of Gene Therapy
NOV 23, 2020
Unusual Mutation Acts as a Kind of Gene Therapy
Clinicians have identified a patient with a rare inherited disorder that disrupts the production of fresh blood cells, a ...
Loading Comments...